Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Anovulation 1

Interventions

Omeprazole 2soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1epigallocatechin gallate 1Vitamin D 1Sulindac 1Sodium Salicylate 1Riluzole 1Radiotherapy, Conformal 1Naproxen 1Febuxostat 1Etanercept 1Dexlansoprazole 1Colchicine 1ClinOleic 1Ascorbic Acid 1Art Therapy 1Allopurinol 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Inflammation × Sodium Salicylate × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡